Target intelligence / Profile preview

Pathogen competitive exclusion

Molecular classification
Other
01

Overview

Pathogen competitive exclusion is not a specific molecule or receptor, but rather a biological phenomenon where beneficial microorganisms—such as probiotics—prevent pathogenic microbes from establishing themselves in an environment like the gut. This occurs primarily through competition for limited resources such as nutrients and physical space, making it difficult for harmful bacteria to adhere to host tissues and multiply[1][3]. The process can also involve antagonistic mechanisms, such as the production of antimicrobial substances or depletion of essential ions required by pathogens[8]. In applied settings, this principle is used in food safety and animal health—for example, introducing probiotic strains into poultry to reduce Salmonella colonization[3]. While highly relevant in infection control and microbiome management, "pathogen competitive exclusion" does not refer to a discrete molecular target suitable for drug binding or direct therapeutic modulation; instead, it describes an ecological interaction among microbial populations. Note: This entry is considered incorrect as a therapeutic target because it refers to a process/mechanism rather than a defined molecular entity like an enzyme or receptor.

Other names
Competitive exclusionCompetitive displacementGause's law (when referring to the ecological principle)
02

Mechanism of action

Competition for nutrients and space by beneficial microbes (e.g., probiotics) prevents pathogens from adhering to host tissues and proliferating[1][3][8]. Antagonism through production of antimicrobial compounds or depletion of essential ions (e.g., manganese scavenging by Lactobacillus)[3][8].

03

Biological functions

Inhibition of pathogen colonizationMaintenance of microbiome balancePrevention of disease development
04

Disease associations

InfectionOther
05

Safety considerations

Potential disruption of normal microbiota if not properly balancedRisk that introduced microbes could become opportunistic pathogens in immunocompromised individuals (inferred from general knowledge)

Beyond the preview

Go deeper on Pathogen competitive exclusion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen competitive exclusion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call